Tumor radiosensitizers-current status of development of various approaches: Report of an International Atomic Energy Agency meeting

Conclusion: Specific recommendations were made for more preclinical studies with certain of the agents and for clinical trials that would be suitable for industrialized countries, as well as trials that were considered more appropriate for developing countries.